Martha Shadan - SEC Filing Summary

This filing details transactions related to dividend equivalent rights (DERs) for Martha Shadan, a director at LeMaitre Vascular Inc. The transactions occurred on September 3, 2026, and involved the acquisition of DERs tied to restricted stock unit and performance share unit awards granted on various dates between December 2023 and December 2025. These DERs are economic equivalents of common stock. The filing also includes a Limited Power of Attorney document, appointing specific individuals to execute SEC forms on behalf of Martha Shadan, including Forms 3, 4, and 5, and Schedules 13D and 13G, in her capacity as a director. The power of attorney remains in effect until Shadan is no longer required to file such forms or until earlier revoked.